Unmanned Aircraft Systems
Pharma
The use of Augmentive Artificial Intelligence (AAI) has been increasing in various sectors of society, particularly the pharma industry. This includes drug discovery and development, drug repurposing, improving pharma productivity, and clinical trials, among others; such use reduces the human workload as well as achieving targets in a short period of time. Excaming crosstalk between the tools and techniques utilized in AI, ongoing challenges, and ways to overcome them, along with the future of AAI in the pharma industry.
Healthcare
Augmentative Artificial intelligence (AAI) has the potential to transform how healthcare is delivered, it can support improvements in care outcomes, patient experience and access to healthcare services. It can increase productivity and the efficiency of care delivery and allow healthcare systems to provide more and better care to more people. Valmiz can help improve the experience of healthcare practitioners, enabling them to spend more time in direct patient care along with all financial bookkeeping while reducing burnout.
Defense
Current AI systems are prone to hallucinating, which means they sometimes provides confident responses not justified by its training, such as doing something that’s only favorable to the machine itself and the machine’s own survival, both of which may be detrimental to humans. In a defense setting, where militaries cannot afford to have a system that makes wrong guesses, the value proposition of using gated data for a wide range of processes remains critical to operations. Service members need to be able to work with a system that aids them and does not try to one-up them by pretending that it’s in a better position to make life-and-death decisions.